Cargando…
Dioscin: A new potential inhibitor of Skp2 for cancer therapy
Autores principales: | Jiang, Wenxiao, Lin, Min, Wang, Zhiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948171/ https://www.ncbi.nlm.nih.gov/pubmed/31901855 http://dx.doi.org/10.1016/j.ebiom.2019.12.002 |
Ejemplares similares
-
Skp2 and Skp2B team up against Rb and p53
por: Germain, Doris
Publicado: (2011) -
Cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth
por: Zhou, Li, et al.
Publicado: (2019) -
Potent effects of dioscin against obesity in mice
por: Liu, Min, et al.
Publicado: (2015) -
Skp2 is a Promising Therapeutic Target in Breast Cancer
por: Wang, Zhiwei, et al.
Publicado: (2012) -
Recent Advances in the Pharmacological Activities of Dioscin
por: Yang, Longfei, et al.
Publicado: (2019)